The topoisomerase I inhibitor topotecan increases the sensitivity of prostate tumor cells to TRAIL/Apo-2L-induced apoptosis (Q44481210)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | The topoisomerase I inhibitor topotecan increases the sensitivity of prostate tumor cells to TRAIL/Apo-2L-induced apoptosis |
scientific article |
Statements
1 reference
The topoisomerase I inhibitor topotecan increases the sensitivity of prostate tumor cells to TRAIL/Apo-2L-induced apoptosis (English)
1 reference
Thomas S Griffith
1 reference
Troy J Kemp
1 reference
14 June 2003
1 reference
1 reference
52
1 reference
3
1 reference
175-184
1 reference
Identifiers
1 reference
1 reference